Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.666 EUR | -0.67% | -3.48% | -67.35% |
May. 14 | Biophytis unveils design for obesity study | CF |
May. 14 | Biophytis SA Announces the Design of its Phase 2 OBA Clinical Study in Obesity | CI |
Sales 2024 * | - | Sales 2025 * | 4.8M 5.18M | Capitalization | 1.91M 2.06M |
---|---|---|---|---|---|
Net income 2024 * | -19M -20.52M | Net income 2025 * | -16M -17.28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.4 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.58% |
1 day | -0.67% | ||
1 week | -3.48% | ||
Current month | -3.48% | ||
1 month | -18.78% | ||
3 months | -59.39% | ||
6 months | -70.27% | ||
Current year | -67.35% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.666 | -0.67% | 8,738 |
24-06-06 | 0.6705 | -1.38% | 10,453 |
24-06-05 | 0.6799 | +1.45% | 9,978 |
24-06-04 | 0.6702 | -1.74% | 27,178 |
24-06-03 | 0.6821 | -1.14% | 12,524 |
Real-time Euronext Paris, June 07, 2024 at 09:29 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-67.35% | 2.06M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ALBPS Stock